WO2002052272A3 - Screening-verfahren zum nachweis von reversiblen protein-protein wechselwirkungen - Google Patents

Screening-verfahren zum nachweis von reversiblen protein-protein wechselwirkungen Download PDF

Info

Publication number
WO2002052272A3
WO2002052272A3 PCT/EP2001/015265 EP0115265W WO02052272A3 WO 2002052272 A3 WO2002052272 A3 WO 2002052272A3 EP 0115265 W EP0115265 W EP 0115265W WO 02052272 A3 WO02052272 A3 WO 02052272A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein
technique
screening method
detecting
interactions
Prior art date
Application number
PCT/EP2001/015265
Other languages
English (en)
French (fr)
Other versions
WO2002052272A2 (de
Inventor
Oliver Rocks
Alfred Wittinghofer
Original Assignee
Evotec Ag
Max Planck Gesellschaft
Oliver Rocks
Alfred Wittinghofer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evotec Ag, Max Planck Gesellschaft, Oliver Rocks, Alfred Wittinghofer filed Critical Evotec Ag
Priority to EP01986933A priority Critical patent/EP1370868A2/de
Priority to AU2002238479A priority patent/AU2002238479A1/en
Publication of WO2002052272A2 publication Critical patent/WO2002052272A2/de
Publication of WO2002052272A3 publication Critical patent/WO2002052272A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures

Abstract

Gegenstand der Erfindung sind Verfahren und Assays zum Nachweis von Protein-Protein Wechselwirkungen und zum testen von Wirkstoffen in Expressionssystemen wie Zellen, wobei ein Protein I mit einem Protein II interagiert, wobei ein Transfer des Protein I in ein Zellkompartiment erfolgt, in dem sowohl Protein I als auch Protein II natürlicherweise nicht vorkommen, und bei Nachweis von Protein II in dem Kompartiment, in das Protein I transferiert wurde, eine Wechselwirkung zwischen Protein I und Protein II festgestellt wird.
PCT/EP2001/015265 2000-12-23 2001-12-21 Screening-verfahren zum nachweis von reversiblen protein-protein wechselwirkungen WO2002052272A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP01986933A EP1370868A2 (de) 2000-12-23 2001-12-21 Methode und screening-verfahren zum nachweis von reversiblen protein-protein wechselwirkungen
AU2002238479A AU2002238479A1 (en) 2000-12-23 2001-12-21 Technique and screening method for detecting reversible protein-protein interactions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10064972 2000-12-23
DE10064972.6 2000-12-23

Publications (2)

Publication Number Publication Date
WO2002052272A2 WO2002052272A2 (de) 2002-07-04
WO2002052272A3 true WO2002052272A3 (de) 2003-07-10

Family

ID=7668947

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/015265 WO2002052272A2 (de) 2000-12-23 2001-12-21 Screening-verfahren zum nachweis von reversiblen protein-protein wechselwirkungen

Country Status (3)

Country Link
EP (1) EP1370868A2 (de)
AU (1) AU2002238479A1 (de)
WO (1) WO2002052272A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114615B2 (en) 2006-05-17 2012-02-14 Cernostics, Inc. Method for automated tissue analysis

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090131270A1 (en) * 2004-08-02 2009-05-21 Cellumen, Inc.A Corporation Methods for the detection of molecular interactions within cells
EP3553527A1 (de) 2011-03-17 2019-10-16 Cernostics, Inc. Systeme und zusammensetzungen zur diagnose von barrett-ösophagen und verfahren zur verwendung davon

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000005410A2 (en) * 1998-07-22 2000-02-03 Technion Research And Development Foundation Ltd. Method for detecting protein-protein interactions and a kit therefor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000005410A2 (en) * 1998-07-22 2000-02-03 Technion Research And Development Foundation Ltd. Method for detecting protein-protein interactions and a kit therefor

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
PERANDER MARIA ET AL: "Nuclear import and export signals enable rapid nucleocytoplasmic shuttling of the atypical protein kinase C lambda.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 276, no. 16, 13 December 2000 (2000-12-13), pages 13015 - 13024, XP002175456, ISSN: 0021-9258 *
RHEE YOON ET AL: "A genetic system for detection of protein nuclear import and export", NATURE BIOTECHNOLOGY, NATURE PUBLISHING, US, vol. 18, no. 4, April 2000 (2000-04-01), pages 433 - 437, XP002168963, ISSN: 1087-0156 *
SCHNEIDER STEFAN ET AL: "Mutagenesis and selection of PDZ domains that bind new protein targets.", NATURE BIOTECHNOLOGY, vol. 17, no. 2, February 1999 (1999-02-01), pages 170 - 175, XP002175455, ISSN: 1087-0156 *
ZHANG MING JIE ET AL: "Tolerance of diverse amino acid substitutions at conserved positions in the nuclear export signal (NES) of HIV-1 Rev.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 243, no. 1, 4 February 1998 (1998-02-04), pages 113 - 116, XP002175457, ISSN: 0006-291X *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114615B2 (en) 2006-05-17 2012-02-14 Cernostics, Inc. Method for automated tissue analysis
US8597899B2 (en) 2006-05-17 2013-12-03 Cernostics, Inc. Method for automated tissue analysis

Also Published As

Publication number Publication date
EP1370868A2 (de) 2003-12-17
AU2002238479A1 (en) 2002-07-08
WO2002052272A2 (de) 2002-07-04

Similar Documents

Publication Publication Date Title
WO2002077604A3 (en) Labeled cells for use as an internal functional control in rare cell detection assays
AU2610101A (en) Methods and systems for monitoring intracellular binding reactions
WO2002029600A3 (de) Zellenarordnung mit segmentierterwischenzellstruktur
ATE462014T1 (de) Bodipy aminoacetaldehyd diethyl acetal
AU2002243397A1 (en) Multiple array system for integrating bioarrays
WO2000001845A3 (de) Verfahren zur frühen diagnose von carcinomen
WO2007001986A3 (en) Methods of detecting nucleic acids in individual cells and of identifying rare cells from large heterogeneous cell populations
WO2003048300A3 (en) Methods of identifying cellular target molecules
DE59800215D1 (de) Mikroinjektionsverfahren zum Einbringen eines Injektionsstoffes, insbes. fremdes, genetisches Material, in Prokaryoten-und Eukaryotenzellen, sowie Zellkompartimente von letzteren (Plastiden, Zellkerne), sowie Nanopipette hierzu
EP0803577A3 (de) Verfahren zur Detektion und/oder Bestimmung von ATP aus Mikroorganismcellen in einer Probe
AU2849300A (en) Methods and assay kits for detecting mononuclear cell phenotype
WO2000005410A3 (en) Method for detecting protein-protein interactions and a kit therefor
WO2005113802A3 (en) Genotoxic testing
WO2000007017A3 (en) Method of high-throughput screening
WO2005006960A3 (en) Detection of cell membrane-associated proteins using membrane fragments displayed on encoded microparticle arrays
WO2002052272A3 (de) Screening-verfahren zum nachweis von reversiblen protein-protein wechselwirkungen
WO2003034025A3 (en) Methods and reagents for improved cell-based assays
AU5352901A (en) Method for quantification of akt protein expression
WO2005089509A3 (en) High throughput assay systems and methods for identifying agents that alter expression of cellular proteins
AU2003219114A1 (en) Method and kit for detecting membrane protein-protein interactions
WO2000011472A3 (de) Nachweis von zellen mittels spezifischer zellwand-bindender domänen (cbd) von zellwand-bindenden proteinen
WO2005014847A3 (en) Reagents, methods and kits for detecting feed enzymes
WO2003018792A1 (fr) Procede de detection d'une substance toxique
WO2007071250A3 (en) Method for detection of l523s expression in biological samples
WO2005028677A3 (en) Systems and methods for determining cell type composition of mixed cell populations using gene expression signatures

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001986933

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001986933

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001986933

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP